{"nct_id":"NCT00841646","title":"Safety and Immunogenicity of Two Doses of Monovalent Inactivated Influenza Vaccine That is Adjuvanted With MF59C.1 (MF59) and Uses a Surface Antigen From a Potential Pandemic Virus Strain Candidate (H5N1) in Adult and Elderly Subjects","status":"COMPLETED","status_verified_date":"2011-12","start_date":"2008-12","start_date_type":null,"primary_completion_date":"2009-07","primary_completion_date_type":"ACTUAL","completion_date":"2009-11","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["NVS"]}